Keçi Genetik Kusuru: Mukopolisakkaridoz Tip III D (MPS III D)

Yıl 2023, Sayı: 378, 22 - 28, 30.12.2023

Yasemin Gedik , Orhan Kavuncu

https://doi.org/10.33724/zm.1340073

Öz

Lizozomlar, makromoleküllerin parçalanmasından sorumlu yaklaşık 50 farklı hidrolitik enzim içeren önemli hücre içi organellerdir. Bu enzimleri kodlayan genlerdeki mutasyonlar, lizozomal depo hastalıkları adı verilen genetik bozukluklara neden olur. Mukopolisakkaridoz tip III D (MPS III D) otozomal resesif kalıtım gösteren lizozomal depo hastalıklarından birisidir. MPS III D, heparan sülfatın yıkılma sürecinde yer alan N-asetilglukozamin-6-sulfataz (G6S/GNS) enziminin eksikliğinde ortaya çıkar. Keçilerde MPS III D tanımlanmış ve karakterize edilmiştir. Keçilerde MPS III D, G6S enzim eksikliği nonsense bir mutasyon sonucudur. Keçilerde G6S enzim eksikliği, birincil olarak katabolize olmamamış heparan sülfatın lizozomlarda birikmesine ve merkezi sinir sistemi ve somatik hücrelerde sitoplazmik vakuolasyona neden olur. Bu hastalığa sahip keçilerde görülen semptomlar ve şiddetleri oldukça değişken olmakla birlikte ana semptomlar motor gelişiminde ve büyümede gerilik ve erken ölümdür. Bu derleme keçi MPS III D genetik kusuruna genel bir bakış sunmaktadır.

Anahtar Kelimeler

genetik kusur, lizozomal depo hastalıkları, keçi

Goat’s Genetic Disorder: Mucoplysaccharidosis III D (MPS III D)

Öz

Lysosomes are important intracellular organelles that contain about 50 different hydrolytic enzymes responsible for degragation of macromolecules. Mutations in the genes that encode these enzymes are caused genetic disorders called lysosomal storage diseases. Mucoplysaccharidosis III D (MPS III D) is one of the autosomal recessive lysosomal storage diseases. MPS III D is due to the deficiency of the enzyme N-acetylglucosamine-6-sulfatase (G6S/GNS), which is involved in step-wise the degradation of heparan sulfate. MPS III D has been identified and characterized in goats. In goat MPS IIID, the G6S enzyme deficiency is result of a nonsense mutation. Deficiency of G6S enzyme activity in goat leads to primary accumulation of uncatabolized heparan sülfat in lysosomes and marked cytoplasmic vacuolation in the central nervous system and somatic tissues. Although the symptoms and severity of symptoms in goats with this disorder are highly variable, the main symptoms are delayed motor development, growth retardation and early death. This review gives on overview on goats MPS IIID genetic disorder.

Anahtar Kelimeler

genetic disorder, lysosomal storage diseases, goat

Kaynakça

• Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2008). Molecular Biology of the Cell (5th ed.). Garland Science.
• Amills, M., Capote, J. and Tosser-Klopp, G. (2017). Goat domestication and breeding: a jigsaw of historical, biological and molecular data with missing pieces. Animal Genetics, 48: 631-644. https://doi.org/10.1111/age.12598
• Andrade, F., Aldámiz-Echevarría, L., Llarena, M., & Couce, M. L. (2015). Sanfilippo syndrome: Overall review. Pediatrics International, 57, 331–338.
• Ballabio, A., Bonifacino, J.S. (2020). Lysosomes as dynamic regulators of cell and organismal homeostasis. Nature Reviews Molecular Cell Biology, 21, 101–118 https://doi.org/10.1038/s41580-019-0185-4
• Batten G.J. (2014). A new breeding pathway to improve meat goats. Livestock Research for Rural Development, 26, Article #155.
• Bonam, S.R., Wang, F. & Muller, S. (2019). Lysosomes as a therapeutic target. Nature Review Drug Discovery 18, 923–948. https://doi.org/10.1038/s41573-019-0036-1
• Cavanagh, K.T., Leipprandt, J.R., Jones, M.Z., & Friderici, K. (1995). Molecular defect of caprine N-acetylglucosamine-6-sulphatase deficiency. A single base substitution creates a stop codon in the 5'-region of the coding sequence. Journal of Inherited Metabolic Disease, 18; 96.
• Cimaz, R., La Torre, F. (2014). Mucopolysaccharidoses. Current Rheumatology Reports, 16, 389 https://doi.org/10.1007/s11926-013-0389-0
• Dong Y., Zhang X., Xie M., Arefnezhad B., Wang Z., Wang W., Feng S., Huang G., Guan R., Shen W., Bunch R., McCulloch R., Li Q., Li B., Zhang G., Xu X., Kijas J.W., Salekdeh G. H., Wang W. & Jiang Y. (2015). Reference genome of wild goat (capra aegagrus) and sequencing of goat breeds provide insight into genic basis of goat domestication. BMC Genomics 16, 431 https://doi.org/10.1186/s12864-015-1606-1
• Downs-Kelly, E., Jones, M.Z., Alroy, J., Cavanagh, K.T., King, B., Lucas, R.E., Baker, J.C., Kraemer, S.A., & Hopwood, J.J. (2000). Caprine Mucopolysaccharidosis IIID: A Preliminary Trial of Enzyme Replacement Therapy. Journal of Molecular Neuroscience, 15(3), 251–262.
• Escolar, M., Bradshaw, J., Byers, V. T., Giugliani, R., Golightly, L., Lourenço, C. M., McDonald, K., Muschol, N., Newsom-Davis, I., O’Neill, C., Peay, H. L., Siedman, J., Solano, M. L., Wirt, T., Wood, T., & Zwaigenbaum, L.. (2020). Development of a Clinical Algorithm for the Early Diagnosis of Mucopolysaccharidosis III. Journal of Inborn Errors of Metabolism and Screening, 8, e20200002. https://doi.org/10.1590/2326-4594-JIEMS-2020-0002
• Fenzl, C. R., Teramoto, K., & Moshirfar, M. (2015). Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses. Clinical ophthalmology (Auckland, N.Z.), 9, 1633–1644. https://doi.org/10.2147/OPTH.S78368
• Gedik, Y. (2017). Keçi populasyonlarının mukopolisakkaridoz tip III D genetik kusuru bakımından tanımlanması. Ankara Üniversitesi Fen Bilimleri Enstitüsü.
• Gedik, Y., & Kavuncu, O. (2017). Detection of N-Acetylglucosamine-6-Sulfatase (GNS) Gene Mutation Causing MPS IIID Genetic Disorder in Turkey Native Goats. Selcuk Journal of Agriculture and Food Sciences, 31(2), 82-85.
• Gedik, Y., & Kavuncu, O. (2020, August 12 - 14). Caprine Mucopolysaccharidosis IIID (MPS IIID) [Conference presentation]. ICABGEH – 20, İzmir, Turkey.
• Gedik, Y., & Kavuncu, O. (2021). Determination of mucopolysaccharidosis IIID in some goat breeds. Turkish Journal of Veterinary & Animal Sciences, 45(5), 964-968.
• Haskins M. E. (2007). Animal models for mucopolysaccharidosis disorders and their clinical relevance. Acta paediatrica (Oslo, Norway : 1992), 96(455), 56–62. https://doi.org/10.1111/j.1651-2227.2007.00211.x
• Hoard, H. M., Leipprandt, J. R., Cavanagh, K. T., Truscott, N. K., Levene, B. A., Friderici, K. H., & Jones, M. Z. (1998). Determination of genotypic frequency of caprine mucopolysaccharidosis IIID. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 10(2), 181–183. https://doi.org/10.1177/104063879801000212
• Jones, M. Z., Alroy, J., Downs-Kelly, E., Lucas, R. E., Kraemer, S. A., Cavanagh, K. T., King, B., & Hopwood, J. J. (2004). Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations. Journal of molecular neuroscience : MN, 24(2), 277–291. https://doi.org/10.1385/JMN:24:2:277
• Khan S.A., Mason R.W., Kobayashi H., Yamaguchi S., Tomatsu S., (2020). Advances in glycosaminoglycan detection, Molecular Genetics and Metabolism, 130 (2), 101-109. https://doi.org/10.1016/j.ymgme.2020.03.004.
• Kido, J., Sugawara, K., & Nakamura, K. (2023). Gene therapy for lysosomal storage diseases: Current clinical trial prospects. Frontiers in genetics, 14, 1064924. https://doi.org/10.3389/fgene.2023.1064924
• Kingma, S.D.K., Bodamer, O.A., Wijburg, F.A. (2015). Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening. Best Practice & Research Clinical Endocrinology & Metabolism, 29 (2), 145-157. https://doi.org/10.1016/j.beem.2014.08.004.
• Kobayashi, H. (2019). Recent trends in mucopolysaccharidosis research. Journal of Human Genetics, 64, 127–137 https://doi.org/10.1038/s10038-018-0534-8
• Lavery, C., Hendriksz, C.J. & Jones, S.A. (2017). Mortality in patients with Sanfilippo syndrome. Orphanet Journal of Rare Diseases 12, 168. https://doi.org/10.1186/s13023-017-0717-y
• Leipprandt, J. R., Friderici, K., Sprecher, D. J., & Jones, M. Z. (1995). Prenatal testing for caprine N-acetylglucosamine-6-sulphatase deficiency and sex identification. Journal of inherited metabolic disease, 18(5), 647–648. https://doi.org/10.1007/BF02436016
• Litjens, T., Bielicki, J., Anson, D. S., Friderici, K., Jones, M. Z., & Hopwood, J. J. (1997). Expression, purification and characterization of recombinant caprine N-acetylglucosamine-6-sulphatase. The Biochemical journal, 327 ( Pt 1)(Pt 1), 89–94. https://doi.org/10.1042/bj3270089
• Luo, J., Wang, W., & Sun, S. (2019). Research advances in reproduction for dairy goats. Asian-Australasian journal of animal sciences, 32(8), 1284–1295. https://doi.org/10.5713/ajas.19.0486
• Muenzer, J. (2014). Early initiation of enzyme replacement therapy for the mucopolysaccharidoses. Molecular Genetics and Metabolism, 111 (2), 63-72. https://doi.org/10.1016/j.ymgme.2013.11.015
• Nair, V., Belanger, E.C., Veinot,J.P. (2019). Lysosomal storage disorders affecting the heart: a review. Cardiovascular Pathology, 39, 12-24. https://doi.org/10.1016/j.carpath.2018.11.002.
• Nomura, K., Yonezawa, T., Mano, S., Kawakami, S., Shedlock, A. M., Hasegawa, M., & Amano, T. (2013). Domestication process of the goat revealed by an analysis of the nearly complete mitochondrial protein-encoding genes. PloS one, 8(8), e67775. https://doi.org/10.1371/journal.pone.0067775.
• Parenti, G., Medina, D. L., & Ballabio, A. (2021). The rapidly evolving view of lysosomal storage diseases. EMBO molecular medicine, 13(2), e12836. https://doi.org/10.15252/emmm.202012836
• Platt, F. M., d'Azzo, A., Davidson, B. L., Neufeld, E. F., & Tifft, C. J. (2018). Lysosomal storage diseases. Nature reviews. Disease primers, 4(1), 27. https://doi.org/10.1038/s41572-018-0025-4
• Rastall D. PW & Amalfitano A. (2015). Recent advances in gene therapy for lysosomal storage disorders, The Application of Clinical Genetics, 8, 157-169, DOI: 10.2147/TACG.S57682
• Stapleton, M., Kubaski, F., Mason, R.W., Shintaku, H., Kobayashi, H., Yamaguchi, S., Taketani, T., Suzuki, Y., Orii,K., Orii, T., Fukao, T., Tomatsu, S. (2020). Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS. Molecular Genetics and Metabolism Reports, 22, 100563. https://www.sciencedirect.com/science/article/pii/S2214426919302009
• Simonaro, C. M. (2016). Lysosomes, Lysosomal Storage Diseases, and Inflammation. Journal of Inborn Errors of Metabolism and Screening, 4, https://doi.org/10.1177/2326409816650465
• Smith, M.C. and Sherman, D.M. (2009). Goat Medicine, (2nd ed.) Wiley-Blackwell
• Stepien, K. M., Roncaroli, F., Turton, N., Hendriksz, C. J., Roberts, M., Heaton, R. A., & Hargreaves, I. (2020). Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review. Journal of Clinical Medicine, 9(8), 2596. https://doi.org/10.3390/jcm9082596
• Thompson, J. N., Jones, M. Z., Dawson, G., & Huffman, P. S. (1992). N-acetylglucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID). Journal of inherited metabolic disease, 15(5), 760–768. https://doi.org/10.1007/BF01800018
• Ün C. (2014). Keçi Medeniyeti. Ayrıntı yayınları.
• Vasilev, F., Sukhomyasova, A., & Otomo, T. (2020). Mucopolysaccharidosis-Plus Syndrome. International Journal of Molecular Sciences, 21(2), 421. https://doi.org/10.3390/ijms21020421
• Wasiksiri, S., Sripongpun, S., Ratanaphan, A., Sookras, P. (2013). A Survey to Determine the Presence of the Nacetylglucosamine-6-sulfatase (G6S) Gene Mutation in Anglo-Nubian Goats in Southern Thailand. Thai Journal of Veterinary Medicine, 43 (1): 99-103.
• Zheng, Z., Wang, X., Li, M., Li, Y., Yang, Z., Wang, X., Pan, X., Gong, M., Zhang, Y., Guo,Y., Wang, Y., Liu, J., Cai, Y., Chen, Q., Okpeku, M., Colli, L., Cai, D., Wang, K., Huang, S., Sonstegard, T.S., Esmailizadeh, A., Zhang, W., Zhang, T., Xu, Y., Xu, N., Yang, Y., Han, J., Chen, L., Lesur, J., Daly, K.G., Bradley, D.G., Heller, R., Zhang, G., Wang, W., Chen, Y., Jiang, Y. (2020). The origin of domestication genes in goats. Science Advances, 6, 21.